June 30, 2016
The novel anti-HIV agent Genvoya Combination Tablets (elvitegravir + cobicistat + emtricitabine + tenofovir alafenamide (TAF)) will be available on the Japanese market from July 8, Japan Tobacco and Torii Pharmaceutical announced on June 29 upon the drug’s NHI price...read more